Search research articles
Contact Us
Filters
Showing results (131-140 of 195) with videos related to
Page
of 20
Sort By:
FEBS Letters
|
December 14, 2001
A point mutant of human sphingosine kinase 1 with increased catalytic activity
S M Pitson, P A Moretti, J R Zebol, et al.
Atherosclerosis
|
June 28, 2001
Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins
M A Clay, D H Pyle, K A Rye, et al.
Blood
|
October 1, 1995
Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT
G W Cockerill, A G Bert, G R Ryan, et al.
The Journal of Experimental Medicine
|
May 1, 1986
Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells
A F Lopez, C G Begley, D J Williamson, et al.
Blood
|
March 15, 1991
Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level
G R Ryan, S E Milton, A F Lopez, et al.
Growth Factors (Chur, Switzerland)
|
January 1, 1992
Three essential promoter elements mediate tumour necrosis factor and interleukin-1 activation of the granulocyte-colony stimulating factor gene
M F Shannon, L S Coles, R K Fielke, et al.
The Journal of Experimental Medicine
|
January 1, 1988
Recombinant human interleukin 5 is a selective activator of human eosinophil function
A F Lopez, C J Sanderson, J R Gamble, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1991
Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils
C S Wong, J R Gamble, M P Skinner, et al.
Blood
|
April 1, 1996
Extracellular truncations of h beta c, the common signaling subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, lead to ligand-independent activation
R J D'Andrea, S C Barry, P A Moretti, et al.
Immunology
|
August 1, 1987
Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines
W A Sewell, P A de Moerloose, J A Hamilton, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 195) with videos related to
Sort By:
Page
of 20
FEBS Letters
|
December 14, 2001
A point mutant of human sphingosine kinase 1 with increased catalytic activity
S M Pitson, P A Moretti, J R Zebol, et al.
Atherosclerosis
|
June 28, 2001
Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins
M A Clay, D H Pyle, K A Rye, et al.
Blood
|
October 1, 1995
Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT
G W Cockerill, A G Bert, G R Ryan, et al.
The Journal of Experimental Medicine
|
May 1, 1986
Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells
A F Lopez, C G Begley, D J Williamson, et al.
Blood
|
March 15, 1991
Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level
G R Ryan, S E Milton, A F Lopez, et al.
Growth Factors (Chur, Switzerland)
|
January 1, 1992
Three essential promoter elements mediate tumour necrosis factor and interleukin-1 activation of the granulocyte-colony stimulating factor gene
M F Shannon, L S Coles, R K Fielke, et al.
The Journal of Experimental Medicine
|
January 1, 1988
Recombinant human interleukin 5 is a selective activator of human eosinophil function
A F Lopez, C J Sanderson, J R Gamble, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1991
Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils
C S Wong, J R Gamble, M P Skinner, et al.
Blood
|
April 1, 1996
Extracellular truncations of h beta c, the common signaling subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, lead to ligand-independent activation
R J D'Andrea, S C Barry, P A Moretti, et al.
Immunology
|
August 1, 1987
Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines
W A Sewell, P A de Moerloose, J A Hamilton, et al.
Page
of 20